OpenResearchAlpha

Journal of Participatory Medicine · 19 Nov 2026

Gamified Self-Care Mobile App for Lifestyle Support in Children With Leukemia: Development and Randomized Controlled Trial

Fatemeh Karimih-index 0, Hamidreza Behnam Vashani, Nahid Aghebati, Tayebeh Pourghaznein, Mohammad Rajabpourh-index 3

0
Citations
no database records one yet
0
Citations in 2026
so far
3
Leading author's h-index
Mohammad Rajabpour, in QAI's scholar index
18
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0
  • Crossref0
  • OpenAlex0
  • Europe PMC0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

Background Children with leukemia undergoing chemotherapy may experience difficulties maintaining a healthy lifestyle and self-care behaviors. Mobile health interventions incorporating interactive and gamified educational features may provide an accessible complement to conventional education. Objective This study aimed to develop and preliminarily evaluate a gamified self-care mobile app and evaluate the effect of the resulting intervention package on lifestyle scores among children aged 7 to 12 years with leukemia undergoing chemotherapy. Methods This 2-phase study was conducted in Mashhad, Iran. In phase 1, the app was developed using evidence from pediatric oncology guidelines and literature and underwent multidisciplinary expert review, user-based quality assessment using the Mobile App Rating Scale, and technical testing. In phase 2, a total of 60 children undergoing chemotherapy were randomly allocated in a 1:1 ratio to an intervention or control group. Both groups received routine face-to-face education and a pamphlet; the intervention group additionally received the Lukemo app and weekly telephone follow-up for 8 weeks. The prespecified primary outcome was the total score of the Persian version of the Pediatric Quality of Life Inventory 4.0 (PedsQL 4.0), assessed at baseline and after 8 weeks. Results Thirty children were allocated to each group in phase 2, and 59 completed the study (intervention: n=29; control: n=30). At 8 weeks, mean lifestyle scores were 89.79 (SD 10.88) in the intervention group and 81.10 (SD 10.57) in the control group (P=.003). The mean change from baseline was 9.10 (SD 10.36) vs 1.00 (SD 2.39) in each group, respectively, yielding a between-group difference in change of 8.10 points (95% CI 4.08-12.12; P<.001). Within-group improvement was significant in the intervention group (P<.001) but not in the control group (P=.05). Conclusions The intervention package incorporating the Lukemo app and weekly telephone support was associated with greater improvement in lifestyle scores over 8 weeks among children with leukemia undergoing chemotherapy. The independent contributions of the app, gamification, and telephone support could not be determined. Longer-term and multicenter studies are needed to assess sustainability and generalizability. Trial Registration Iranian Registry of Clinical Trials IRCT20211007052692N2; https://en.irct.ir/trial/66986

What the data shows

  • No database records a citation yet, as is usual for a paper this new.
  • Mohammad Rajabpour has the highest h-index among the authors (3).

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (5)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (18)

What it cites, from open citation data, with Crossref's record of each.